| Harris Teeter Pharmacy # 149 | |
| 2750 Celanese Rd, Rock Hill, South Carolina 29732 | |
| (803) 329-6262 |
| Name | Harris Teeter Pharmacy # 149 |
|---|---|
| Organization Name | Harris Teeter Llc |
| Location | 2750 Celanese Rd, Rock Hill, South Carolina 29732 |
| Type | Community/Retail Pharmacy |
| Phone | (803) 329-6262 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Buffalo medical researchers led by a team from the University at Buffalo Department of Neurosurgery, will embark on a landmark prospective randomized double-blinded study to test the safety and efficacy of interventional endovascular therapy - dubbed "liberation treatment" - on the symptoms and progression of Multiple Sclerosis.
Aegerion Pharmaceuticals, Inc. today announced that the underwriters of its October 22, 2010 initial public offering have exercised in full their over-allotment option to purchase an additional 750,000 shares of Aegerion's common stock at $9.50 per share, less underwriting discounts and commissions. The option was granted in connection with Aegerion's initial public offering of 5,000,000 shares. The over-allotment option is expected to close on November 2, 2010, subject to customary closing conditions.
Scientists have developed a method to boost the efficiency of CRISPR gene editing in Duchenne muscular dystrophy (DMD), according to a study that could have implications for optimizing gene therapies for other diseases.
Coverage of the Senate's "broad agreement" to create a national health insurance plan continues, with Democratic leaders remaining mum on details while insisting the compromise leaves a "public" option in the bill. (See KHN's Tuesday night breaking news round-up).
› Verified 7 days ago
| NPI Number | 1235240706 |
| Organization Name | HARRIS TEETER, LLC |
| Doing Business As | HARRIS TEETER PHARMACY |
| Type | Community/Retail Pharmacy |
| Address | 2750 Celanese Rd, Rock Hill, SC 29732 |
| Phone Number | 803-329-6262 |
News Archive
Buffalo medical researchers led by a team from the University at Buffalo Department of Neurosurgery, will embark on a landmark prospective randomized double-blinded study to test the safety and efficacy of interventional endovascular therapy - dubbed "liberation treatment" - on the symptoms and progression of Multiple Sclerosis.
Aegerion Pharmaceuticals, Inc. today announced that the underwriters of its October 22, 2010 initial public offering have exercised in full their over-allotment option to purchase an additional 750,000 shares of Aegerion's common stock at $9.50 per share, less underwriting discounts and commissions. The option was granted in connection with Aegerion's initial public offering of 5,000,000 shares. The over-allotment option is expected to close on November 2, 2010, subject to customary closing conditions.
Scientists have developed a method to boost the efficiency of CRISPR gene editing in Duchenne muscular dystrophy (DMD), according to a study that could have implications for optimizing gene therapies for other diseases.
Coverage of the Senate's "broad agreement" to create a national health insurance plan continues, with Democratic leaders remaining mum on details while insisting the compromise leaves a "public" option in the bill. (See KHN's Tuesday night breaking news round-up).
› Verified 7 days ago
News Archive
Buffalo medical researchers led by a team from the University at Buffalo Department of Neurosurgery, will embark on a landmark prospective randomized double-blinded study to test the safety and efficacy of interventional endovascular therapy - dubbed "liberation treatment" - on the symptoms and progression of Multiple Sclerosis.
Aegerion Pharmaceuticals, Inc. today announced that the underwriters of its October 22, 2010 initial public offering have exercised in full their over-allotment option to purchase an additional 750,000 shares of Aegerion's common stock at $9.50 per share, less underwriting discounts and commissions. The option was granted in connection with Aegerion's initial public offering of 5,000,000 shares. The over-allotment option is expected to close on November 2, 2010, subject to customary closing conditions.
Scientists have developed a method to boost the efficiency of CRISPR gene editing in Duchenne muscular dystrophy (DMD), according to a study that could have implications for optimizing gene therapies for other diseases.
Coverage of the Senate's "broad agreement" to create a national health insurance plan continues, with Democratic leaders remaining mum on details while insisting the compromise leaves a "public" option in the bill. (See KHN's Tuesday night breaking news round-up).
› Verified 7 days ago
Piedmont Medical Equipment Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1213 Ebenezer Rd 100, Rock Hill, South Carolina 29732 Phone: (803) 366-6666 | |
Cvs Pharmacy #05679 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1746 Heckle Blvd, Rock Hill, South Carolina 29732 Phone: (803) 366-9400 | |
Cvs Pharmacy #03809 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 609 Cherry Rd, Rock Hill, South Carolina 29732 Phone: (803) 328-6111 | |
Cvs Pharmacy #04288 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2707 Celanese Rd, Rock Hill, South Carolina 29732 Phone: (803) 366-4157 | |
Cvs Pharmacy #16710 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1900 Springsteen Rd, Rock Hill, South Carolina 29730 Phone: (803) 985-3888 |